CEP-1347
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEP-1347, covering 2012-05-10 to 2012-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [Phase 2, Phase 3]